Hi all,
Here are the first results from a trial of Promacta in MDS patients. The patients got a significant increase in the number of megakaryocytic colonies. Platelets is fabricated from megakaryocytes. They don't really tell us much about the trial for example the number of patients and controls or anything about adverse effects.
http://www.ncbi.nlm.nih.gov/pubmed/20688394
Kind regards
Birgitta-A